Answers are grounded in this paper and cite their sources.
This analysis demonstrates accurate HER2 scoring in breast carcinoma, suggesting a reliable tool for pathologists.
Our QIA method can be beneficial to use as a reliable HER2 scoring tool for HER2 classical overexpression and HER2-low in BCs. It was found to be agnostic and provided same accuracy irrespective of IHC assay applied.
No takes yet. Share an insight, caveat, or question.
Cossutta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: